Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. MYO
stocks logo

MYO

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
10.40M
-13.8%
-0.086
+760%
10.78M
+9.61%
-0.083
+3.13%
11.19M
+15.96%
-0.077
-29.55%
Estimates Revision
The market is revising No Change the revenue expectations for Myomo, Inc. (MYO) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 2.22%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+2.22%
In Past 3 Month
Wall Street analysts forecast MYO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MYO is 6.50 USD with a low forecast of 4.00 USD and a high forecast of 10.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast MYO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MYO is 6.50 USD with a low forecast of 4.00 USD and a high forecast of 10.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 1.020
sliders
Low
4.00
Averages
6.50
High
10.50
Current: 1.020
sliders
Low
4.00
Averages
6.50
High
10.50
H.C. Wainwright
H.C. Wainwright
Buy
downgrade
$5
2025-08-12
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$5
2025-08-12
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Myomo to $5 from $9.50 and keeps a Buy rating on the shares. The firm says that while the company's Q2 ended well, there are warning signs ahead as Myomo reported that the number of patients added to its pipeline was significantly lower than expected.
Alliance Global Partners
Buy
maintain
2025-06-26
Reason
Alliance Global Partners
Price Target
2025-06-26
maintain
Buy
Reason
Alliance Global Partners lowered the firm's price target on Myomo to $6.50 from $6.75 and keeps a Buy rating on the shares following the analyst day. The firm cites minor reductions in its revenue forecast for the target trim but remains confident in the positive fundamental progress of the company.
Craig-Hallum
Buy
downgrade
$10 -> $8
2025-06-23
Reason
Craig-Hallum
Price Target
$10 -> $8
2025-06-23
downgrade
Buy
Reason
Craig-Hallum
Buy
downgrade
$11 -> $10
2025-05-08
Reason
Craig-Hallum
Price Target
$11 -> $10
2025-05-08
downgrade
Buy
Reason
Craig-Hallum lowered the firm's price target on Myomo to $10 from $11 and keeps a Buy rating on the shares following a mixed Q1 update. Q2 guidance disappointed, with revenue expected between $9.0M-$9.5M versus Street expectations of $10.9M.
Ascendiant Capital
Edward Woo
Strong Buy
Maintains
$9 → $11
2025-03-17
Reason
Ascendiant Capital
Edward Woo
Price Target
$9 → $11
2025-03-17
Maintains
Strong Buy
Reason
HC Wainwright & Co.
Sean Lee
Strong Buy
Maintains
$7.5 → $9.5
2025-03-12
Reason
HC Wainwright & Co.
Sean Lee
Price Target
$7.5 → $9.5
2025-03-12
Maintains
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Myomo Inc (MYO.A) is -3.07, compared to its 5-year average forward P/E of -11.84. For a more detailed relative valuation and DCF analysis to assess Myomo Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-11.84
Current PE
-3.07
Overvalued PE
1.73
Undervalued PE
-25.42

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-12.62
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
9.61
Undervalued EV/EBITDA
-34.84

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.56
Current PS
0.00
Overvalued PS
4.20
Undervalued PS
0.91
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

MYO News & Events

Events Timeline

(ET)
2025-11-10
16:12:17
Myomo reaffirms FY25 revenue forecast of $40M-$42M, aligning with consensus of $40.19M
select
2025-11-10
16:11:23
Myomo announces Q3 earnings per share of 9 cents, below consensus estimate of 11 cents.
select
2025-08-11 (ET)
2025-08-11
16:16:19
Myomo reports Q2 EPS (11c), consensus (11c)
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.0
11-11SeekingAlpha
Myomo reaffirms its revenue goal of $40M–$42M for 2025, fueled by growth in the O&P channel and MyoConnect.

  • Management Performance: Myomo, Inc. reported a strong Q3 2025 with revenues of $10.1 million, driven by record international sales and increased authorizations, while also announcing a strategic shift in advertising focus and the hiring of a new marketing head.

  • Financial Overview: The company experienced a 10% year-over-year revenue increase, with significant growth in the O&P channel and international markets, although gross margins declined due to rising costs. Operating losses were reported at $3.5 million.

  • Future Outlook: Myomo reiterated its full-year revenue guidance of $40 million to $42 million for 2025, emphasizing plans to diversify revenue streams and improve operating leverage while managing cash burn in 2026.

  • Analyst Sentiment: Analysts expressed constructive curiosity regarding operational details and strategic shifts, while management maintained a confident tone, highlighting progress in pipeline growth and ongoing efforts to address challenges in payer authorizations.

[object Object]
Preview
3.0
11-10SeekingAlpha
Myomo's Earnings Forecast for Q3 2025

  • Earnings Announcement: Myomo (MYO) is set to release its Q3 earnings results on November 10th, after market close.

  • EPS and Revenue Estimates: The consensus EPS estimate is -$0.11, reflecting a 266.7% year-over-year decline, while the revenue estimate is $9.44 million, indicating a 2.5% year-over-year increase.

  • Revisions Overview: Over the past three months, there have been no upward revisions for EPS or revenue estimates, but five downward revisions for each.

  • Future Growth Target: Myomo has revised its revenue growth target for 2025 to between 23% and 29%, citing improvements in lead quality and pipeline conversion.

[object Object]
Preview
4.5
08-13Benzinga
Crude Oil Down 1%; Gevo Shares Spike Higher

  • Stock Market Performance: U.S. stocks saw gains with the S&P 500 up approximately 1%, while the Dow and NASDAQ also rose significantly. Notable movers included 180 Life Sciences Corp, which surged 259% after a private offering, and Gevo, Inc., which increased by 52% following positive Q2 results.

  • Inflation and Commodities: The U.S. annual inflation rate remained steady at 2.7% in July, slightly below expectations, while core inflation reached a five-month high of 3.1%. In commodities, oil prices fell by 1.2%, while silver and copper experienced slight increases.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Myomo Inc (MYO) stock price today?

The current price of MYO is 1.02 USD — it has increased 6.03 % in the last trading day.

arrow icon

What is Myomo Inc (MYO)'s business?

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

arrow icon

What is the price predicton of MYO Stock?

Wall Street analysts forecast MYO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MYO is 6.50 USD with a low forecast of 4.00 USD and a high forecast of 10.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Myomo Inc (MYO)'s revenue for the last quarter?

Myomo Inc revenue for the last quarter amounts to 10.09M USD, increased 9.59 % YoY.

arrow icon

What is Myomo Inc (MYO)'s earnings per share (EPS) for the last quarter?

Myomo Inc. EPS for the last quarter amounts to -0.09 USD, increased 200.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Myomo Inc (MYO)'s fundamentals?

The market is revising No Change the revenue expectations for Myomo, Inc. (MYO) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 2.22%.
arrow icon

How many employees does Myomo Inc (MYO). have?

Myomo Inc (MYO) has 184 emplpoyees as of December 05 2025.

arrow icon

What is Myomo Inc (MYO) market cap?

Today MYO has the market capitalization of 39.01M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free